METHOD FOR PREVENTION OF ATRIAL FIBRILLATION IN OPEN LUNG SURGERIES OF ONCOLOGY DISEASES Russian patent published in 2016 - IPC A61M19/00 A61K31/02 A61K31/4468 A61K31/45 A61P23/00 

FIELD: medicine.

SUBSTANCE: whole surgical intervention involves the continuous infusion of a mix of 0.3% Ropivacaine with Fentanyl 4 mcg/ml and adrenalin 2 mcg/ml at the saturation rate of 8-12 ml/h to be reduced to 4-6 ml/h. The postoperative period involves continuing the infusion of the mix of 0.2% Ropivacaine with Fentanyl 2 mcg/ml and adrenalin 2 mcg/ml. The period of 5-7 days involves the infusion of 0.2% Ropivacaine at the average rate of 4-8 ml/h. With controlling the cardiac rate, from the first postoperative day, the high-selectivity β-adrenoceptor blocking agent bisoprolol is prescribed in a dose of 2.5-10 mg/day and ascorbic acid 250 mg/day.

EFFECT: method provides reducing the probability of postoperative atrial fibrillation, a postoperative need in anaesthetics used for hypnotic and antinociceptive purposes, and also an intraoperative and postoperative need in opioid analgesics during the early postoperative period.

2 tbl, 2 ex